Use of biochemical markers to study and follow patients with osteoarthritis (Q36413086)

14 August 2017

1 reference

title

Use of biochemical markers to study and follow patients with osteoarthritis (English)

1 reference

14 August 2017

0 references

Patrick Garnero

1

1 reference

14 August 2017

1 February 2006

1 reference

Current Rheumatology Reports

14 August 2017

1 reference

14 August 2017

8

1 reference

14 August 2017

1

1 reference

14 August 2017

37-44

1 reference

https://scigraph.springernature.com/pub.10.1007/s11926-006-0023-5

14 August 2017

0 references

cites work

Effects of ibuprofen on molecular markers of cartilage and synovium turnover in patients with knee osteoarthritis

1 reference

12 December 2020

Serum hyaluronan levels and radiographic knee and hip osteoarthritis in African Americans and Caucasians in the Johnston County Osteoarthritis Project.

1 reference

12 December 2020

Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis

1 reference

12 December 2020

Variation of serum hyaluronan with activity in individuals with knee osteoarthritis

1 reference

12 December 2020

Blood-based biomarkers for detecting mild osteoarthritis in the human knee.

1 reference

12 December 2020

Knee cartilage defects: association with early radiographic osteoarthritis, decreased cartilage volume, increased joint surface area and type II collagen breakdown

1 reference

12 December 2020

Cross-sectional association of 10 molecular markers of bone, cartilage, and synovium with disease activity and radiological joint damage in patients with hip osteoarthritis: the ECHODIAH cohort

1 reference

12 December 2020

New serum biochemical markers (Coll 2-1 and Coll 2-1 NO2) for studying oxidative-related type II collagen network degradation in patients with osteoarthritis and rheumatoid arthritis

1 reference

12 December 2020

The type II collagen fragments Helix-II and CTX-II reveal different enzymatic pathways of human cartilage collagen degradation

1 reference

12 December 2020

A new marker for osteoarthritis: Cross-sectional and longitudinal approach

1 reference

12 December 2020

Serum concentration of cartilage oligomeric matrix protein (COMP) is sensitive to physiological cyclic loading in healthy adults.

1 reference

12 December 2020

Serum cathepsin K levels of patients with longstanding rheumatoid arthritis: correlation with radiological destruction

1 reference

12 December 2020

Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis

1 reference

12 December 2020

Toward imaging biomarkers for osteoarthritis

1 reference

12 December 2020

Changes in knee cartilage volume and serum COMP concentration after running exercise

1 reference

12 December 2020

One-year increase of Coll 2-1, a new marker of type II collagen degradation, in urine is highly predictive of radiological OA progression

1 reference

12 December 2020

AGEing and osteoarthritis: a different perspective

1 reference

12 December 2020

The effect on cartilage of different forms of application of postmenopausal estrogen therapy: comparison of oral and transdermal therapy.

1 reference

12 December 2020

Use of the plasma stromelysin (matrix metalloproteinase 3) concentration to predict joint space narrowing in knee osteoarthritis

1 reference

12 December 2020

Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years

1 reference

12 December 2020

Bone marrow abnormalities on magnetic resonance imaging are associated with type II collagen degradation in knee osteoarthritis: a three-month longitudinal study.

1 reference

12 December 2020

Proteomic surveillance of autoimmunity in osteoarthritis: identification of triosephosphate isomerase as an autoantigen in patients with osteoarthritis

1 reference

12 December 2020

Suppression of elevated cartilage turnover in postmenopausal women and in ovariectomized rats by estrogen and a selective estrogen-receptor modulator (SERM).

1 reference

12 December 2020

Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis

1 reference

12 December 2020

Association between spine disc degeneration and type II collagen degradation in postmenopausal women: the OFELY study

1 reference

12 December 2020

Glucosamine sulfate and cartilage type II collagen degradation in patients with knee osteoarthritis: randomized discontinuation trial results employing biomarkers

1 reference

12 December 2020

Urinary CTX-II levels are associated with radiographic subtypes of osteoarthritis in hip, knee, hand, and facet joints in subject with familial osteoarthritis at multiple sites: the GARP study

1 reference

12 December 2020

Increased pentosidine, an advanced glycation end product, in serum and synovial fluid from patients with knee osteoarthritis and its relation with cartilage oligomeric matrix protein

1 reference

12 December 2020

Development and clinical application in arthritis of a new immunoassay for serum type IIA procollagen NH2 propeptide

1 reference

12 December 2020

Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173]

1 reference

12 December 2020

10.1007/S11926-006-0023-5

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16515763